Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of 9,10-oxazinone camptothecin derivative and its application

A derivative, camptothecin technology, applied in the field of camptothecin derivatives, can solve the problem of lack of effective drugs and achieve the effects of reducing the concentration of IL-6 and TNF-α, low drug toxicity, and good therapeutic effect

Active Publication Date: 2021-02-26
深圳瀜新生物科技有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For this extremely harmful inflammation, there is a serious lack of effective drugs at present

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of 9,10-oxazinone camptothecin derivative and its application
  • A kind of 9,10-oxazinone camptothecin derivative and its application
  • A kind of 9,10-oxazinone camptothecin derivative and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Compound 1 preparation of

[0061] 1) The TFA solution of 10-hydroxycamptothecin (100mg, 0.27mmol) and HMTA (80mg, 0.55mmol) was heated and refluxed for 20 hours under the protection of argon. After the reaction was complete, the reaction solution was concentrated, and the concentrated residue Add 20mlH 2 O, then stirred at room temperature for 1 hour, then added 80ml of water to dilute, and washed with saturated NaHCO 3 Solution Adjust the pH of the reaction solution to 8-9, wash the aqueous phase with ethyl acetate, then adjust the pH of the aqueous phase to 1.5, then extract the aqueous phase with ethyl acetate (20ml*5), combine the organic phases, and wash them with 1N hydrochloric acid 、H 2 The organic phase was washed with O and saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated, and the residue was separated by flash column chromatography to obtain compound A (methanol / dichloromethane 1:50 as the eluent system);

[0062] 2) Compo...

Embodiment 2

[0069] Compound 2: preparation of

[0070] Compound 1 (120mg, 026mmol), Sc(OTf) 3 (78mg, 0.16mmol) and DMAP (94mg, 0.78mmol) were dissolved in dry dichloromethane solvent, the reaction mixture was stirred at room temperature for 30 minutes, then Boc-glycine (136mg, 0.78mmol) was added, and the reaction mixture was stirred for 30 minutes Minutes, then DCC (272mg, 1.3mmol) was added, the reaction mixture was stirred overnight at room temperature, then filtered through diatomaceous earth, the filtrate was concentrated and separated by flash column chromatography to obtain compound D (methanol / dichloromethane 1:100 as the elution system).

[0071] TFA (1ml) was added to a solution of compound D (95mg, 0.15mmol) in dichloromethane, and the reaction mixture was stirred at room temperature for 30 minutes, then the reaction solvent was removed, and the residue was dissolved in DMF (2ml), and added to the reaction solution Succinic anhydride (97mg, 0.97mmol) and 4-picoline (73mg, 0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The invention discloses a 9,10-oxazinone camptothecin derivative and its application. The general chemical structure formula is the 9,10-oxazinone camptothecin derivative of the present invention, which has good water solubility, The solubility can reach 3.40mg / mL, and the pH of its aqueous solution is 7-8, which is close to the physiological pH of the human body. Compared with topotecan, the compound of the present invention has better antitumor activity and lower drug toxicity. More importantly, it can be prepared into an oral preparation, which greatly facilitates the patients to take it. The 9,10-oxazinone camptothecin derivative of the present invention can significantly reduce the concentrations of IL-6 and TNF-α in the blood of septic mice, and has a good therapeutic effect on acute inflammation.

Description

technical field [0001] The present invention relates to camptothecin derivatives and applications thereof. Background technique [0002] Camptothecin (CPT) is a cytotoxic alkaloid extracted from Camptotheca involucrata in 1966, and its structural formula is as follows: [0003] [0004] Tumor experiments have proved that camptothecin has obvious anti-tumor activity, especially for gastrointestinal tumors, leukemia, bladder cancer, etc., but it is easy to cause side effects such as bone marrow suppression, vomiting, and hematuria, and it is insoluble in water and insoluble Because of fat, it is not convenient to make suitable dosage forms, which further limits its application. Until 1985, the research confirmed that CPT is a specific inhibitor of topoisomerase Ⅰ, making it a hot spot in the research of anticancer drugs. At present, there are several drugs under clinical development for small molecule inhibitors of topoisomerase I (Topo I). Information on representative ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D491/22A61K31/4745A61P35/00A61P31/04A61P31/12A61P29/00
CPCA61P29/00A61P31/04A61P31/12A61P35/00C07D491/22
Inventor 余慧东李希建黄湧潘培辰侯廷军岑国亮
Owner 深圳瀜新生物科技有限公司